Fact CheckerSign in

NCT07229859Completed

Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening

Source: ClinicalTrials.gov · Last updated 17 Nov 2025

Brief summary (registry, in English)

The goal of this observational study is to learn the efficacy, cosmetic effectiveness and safety of robotic modified radical neck dissection in well-selected cases, through direct comparison with conventional open surgery in low-risk papillary thyroid carcinoma with lateral cervical lymph node metastasis. The main questions it aims to answer are: Does robotic neck dissection provide tumor clearance equivalent to that of the conventional open approach? How does the postoperative complication rate of the robotic technique compare with open surgery? Are patients satisfied with the cosmetic appearance of the wound following robotic neck dissection? Researchers will compare robotic surgery with conventional open surgery to see if it has the same efficacy, cosmetic effectiveness and safety. Participants' postoperative recovery will be followed up, and they will provide pain scores and rate their cosmetic satisfaction with the wound.

Status (registry)
Completed
Study type
Observational
Enrollment
332 (actual)
First submitted
13 Nov 2025
Start date
1 Jan 2018
Primary completion date
31 Dec 2022
Lead sponsor
Ruijin Hospital
NCT number
NCT07229859

What you commit to

  • Study type: Observational
  • Participants enrolled: 332
  • From 1 Jan 2018 to the primary completion date, 31 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • (3) history of neck surgery or radiation therapy;

Other

  • (1) metastatic LNs in level I or VII;
  • (2) metastatic LNs fused with each other or fixed in the neck or extra-nodal extension;
  • (4) extranodal extension;
  • (5) the presence of TERT mutation.

Who the study is looking for

  • (1) PTC with lateral LN metastasis confirmed by fine needle aspiration (FNA) biopsy;
  • (2) maximum tumor size \< 3 cm;
  • (3) without extrathyroidal extension;
  • (4) metastatic LNs in unilateral levels II, III, IV and/or V;
  • (5) number of suspicious metastatic LNs based on preoperative ultrasonography \< 5;
  • (6) maximum metastatic LN diameter \< 3 cm.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ruijin Hospital Shanghai Jiaotong University School of Medicine
Coordinator of this site? Confirm its status
ShanghaiChinaUnknown status

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.